Rite Aid/Revco merger: Would expand largest U.S. drug store chain to 4,500 outlets with projected annual sales of over $11 bil. Camp Hill, Penn.-based Rite Aid, will acquire Revco's 2,100 stores in a $1.8 bil. cash plus stock swap transaction announced Nov. 30. Rite Aid is offering to purchase "at least" 50.1% of Revco shares for $27.50 a share in cash and exchange Rite Aid shares for the remainder. All stores will carry the Rite Aid name and will adopt Rite Aid's internal layout. No top Revco execs are joining Rite Aid and Revco's corporate headquarters in Twinsburg, Ohio, will be closed...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
In this second of a two-part series of articles, US Pharmacopeia CEO Ronald T. Piervincenzi tells the Pink Sheet which animal testing models have alternative options and highlights where further investment and research is needed to develop appropriate alternatives.
A “basket approach” to phasing out animal testing could help identify areas where “moonshot” research is required to implement new approach methodologies, according to EU industry federation EFPIA.
Vertex said it reached “a broad reimbursement agreement” with the National Health Service for its once-daily, triple combination treatment for cystic fibrosis. As for reimbursement in the rest of Europe, the company is targeting Ireland, Denmark and Germany next.